Suppr超能文献

弥漫性神经胶质瘤的外科治疗:神经外科学治疗现状及未来方向。

The surgical management of diffuse gliomas: Current state of neurosurgical management and future directions.

机构信息

Department of Neurological Surgery, University of California, San Francisco, USA.

出版信息

Neuro Oncol. 2023 Dec 8;25(12):2117-2133. doi: 10.1093/neuonc/noad133.

Abstract

After recent updates to the World Health Organization pathological criteria for diagnosing and grading diffuse gliomas, all major North American and European neuro-oncology societies recommend a maximal safe resection as the initial management of a diffuse glioma. For neurosurgeons to achieve this goal, the surgical plan for both low- and high-grade gliomas should be to perform a supramaximal resection when feasible based on preoperative imaging and the patient's performance status, utilizing every intraoperative adjunct to minimize postoperative neurological deficits. While the surgical approach and technique can vary, every effort must be taken to identify and preserve functional cortical and subcortical regions. In this summary statement on the current state of the field, we describe the tools and technologies that facilitate the safe removal of diffuse gliomas and highlight intraoperative and postoperative management strategies to minimize complications for these patients. Moreover, we discuss how surgical resections can go beyond cytoreduction by facilitating biological discoveries and improving the local delivery of adjuvant chemo- and radiotherapies.

摘要

在世界卫生组织最近更新了用于诊断和分级弥漫性神经胶质瘤的病理学标准后,北美和欧洲的主要神经肿瘤学会都建议将最大限度安全切除作为弥漫性神经胶质瘤的初始治疗方法。为了实现这一目标,神经外科医生在制定低级别和高级别神经胶质瘤的手术计划时,应根据术前影像学和患者的表现状态,在可行的情况下进行最大限度切除,并利用每个术中辅助手段将术后神经功能缺损降至最低。虽然手术入路和技术可能有所不同,但必须尽一切努力识别和保护功能皮质和皮质下区域。在这篇关于该领域现状的总结性陈述中,我们描述了有助于安全切除弥漫性神经胶质瘤的工具和技术,并强调了术中及术后管理策略,以最大限度地减少这些患者的并发症。此外,我们还讨论了手术切除如何通过促进生物学发现和改善辅助化疗和放疗的局部递送来超越细胞减灭术。

相似文献

4
Long-term outcomes after supratotal resection of diffuse low-grade gliomas: a consecutive series with 11-year follow-up.
Acta Neurochir (Wien). 2016 Jan;158(1):51-8. doi: 10.1007/s00701-015-2621-3. Epub 2015 Nov 3.
5
Supratotal resection of diffuse gliomas - an overview of its multifaceted implications.
Neurochirurgie. 2017 Jun;63(3):243-249. doi: 10.1016/j.neuchi.2016.09.006. Epub 2017 Feb 7.
10
A new philosophy in surgery for diffuse low-grade glioma (DLGG): oncological and functional outcomes.
Neurochirurgie. 2013 Feb;59(1):2-8. doi: 10.1016/j.neuchi.2012.11.001. Epub 2013 Feb 12.

引用本文的文献

3
Turning attention to tumor-host interface and focus on the peritumoral heterogeneity of glioblastoma.
Nat Commun. 2024 Dec 30;15(1):10885. doi: 10.1038/s41467-024-55243-5.
5
Implications of molecular classifications in glioma surgery.
J Neurooncol. 2025 Feb;171(3):559-569. doi: 10.1007/s11060-024-04883-0. Epub 2024 Nov 12.
6
Spermine Synthase : A Potential Prognostic Marker for Lower-Grade Gliomas.
J Korean Neurosurg Soc. 2025 Jan;68(1):75-96. doi: 10.3340/jkns.2024.0080. Epub 2024 Nov 5.
8
Local therapy in glioma: An evolving paradigm from history to horizons (Review).
Oncol Lett. 2024 Jul 17;28(3):440. doi: 10.3892/ol.2024.14573. eCollection 2024 Sep.
9
Navigated intraoperative ultrasound in pediatric brain tumors.
Childs Nerv Syst. 2024 Sep;40(9):2697-2705. doi: 10.1007/s00381-024-06492-8. Epub 2024 Jun 11.

本文引用的文献

1
Vorasidenib in IDH1- or IDH2-Mutant Low-Grade Glioma.
N Engl J Med. 2023 Aug 17;389(7):589-601. doi: 10.1056/NEJMoa2304194. Epub 2023 Jun 4.
2
Pseudoprogression versus true progression in glioblastoma: what neurosurgeons need to know.
J Neurosurg. 2023 Feb 10;139(3):748-759. doi: 10.3171/2022.12.JNS222173. Print 2023 Sep 1.
3
Key Clinical Principles in the Management of Glioblastoma.
JCO Oncol Pract. 2023 Apr;19(4):180-189. doi: 10.1200/OP.22.00476. Epub 2023 Jan 13.
4
Interactive Effects of Molecular, Therapeutic, and Patient Factors on Outcome of Diffuse Low-Grade Glioma.
J Clin Oncol. 2023 Apr 10;41(11):2029-2042. doi: 10.1200/JCO.21.02929. Epub 2023 Jan 4.
8
Turning on the light for brain tumor surgery: A 5-aminolevulinic acid story.
Neuro Oncol. 2022 Nov 2;24(Suppl 6):S52-S61. doi: 10.1093/neuonc/noac191.
9
Surgically targeted radiation therapy (STaRT) trials for brain neoplasms: A comprehensive review.
Neuro Oncol. 2022 Nov 2;24(Suppl 6):S16-S24. doi: 10.1093/neuonc/noac130.
10
Laser hyperthermia: Past, present, and future.
Neuro Oncol. 2022 Nov 2;24(Suppl 6):S42-S51. doi: 10.1093/neuonc/noac208.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验